Mesothelioma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatima Shaukat, MD [2]Parminder Dhingra, M.D. [3]

Overview

There is insufficient evidence to recommend routine screening for mesothelioma.

Screening

There is no universally agreed protocol for screening people who have been exposed to asbestos.
However some research indicates that the serum osteopontin level might be useful in screening asbestos-exposed people for mesothelioma.
The level of soluble mesothelin-related protein is elevated in the serum of about 75% of patients at diagnosis and it has been suggested that it may be useful for screening.^[1]

References

↑ “Soluble mesothelin-related protein–a blood test for mesothelioma” by B. W. Robinson, J. Creaney, R. Lake, A. Nowak, A. W. Musk, N. de Klerk, P. Winzell, K. E. Hellstrom and I. Hellstrom in Lung Cancer (2005) volume 49, pages S109-S111 Template:Entrez Pubmed.

Overview